Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

U.S. patent issues for Regeneron's Ang2 protein

Oct. 26, 1998

Phase III trial of Nutropin Depot successfully completed; NDA filing slated for 1999

Oct. 23, 1998

Takeda discontinues further development of osteoporosis drug

Oct. 23, 1998

Weight-loss drugs: some disappoint, others look more promising

Oct. 22, 1998

Amylin announces positive phase I trial results for diabetes compound

Oct. 22, 1998

Phase II study of BB-10010 for maintaining hematopoiesis in patients undergoing chemotherapy

Oct. 22, 1998

Propionic acid derivatives from Nippon Chemiphar useful for diabetes and related disorders

Oct. 21, 1998

Daiichi's new squalene synthase inhibitors

Oct. 21, 1998

HMG-CoA reductase inhibitor now under regulatory review in Japan

Oct. 21, 1998

Yamanouchi applies for approval of oral bisphosphonate in Japan

Oct. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...